Bioforce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
May 04, 2020 at 11:41 am EDT
Share
BioForce Nanosciences Holdings, Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced net loss was USD 158.041 million compared to USD 12,852 a year ago. Basic loss per share from continuing operations was USD 10.35. Diluted loss per share from continuing operations was USD 10.35.
BioForce Nanosciences Holdings, Inc. is a provider of natural vitamins, minerals and other nutritional supplements, powders and beverages, formulated to promote a healthier lifestyle for active individuals in all age ranges. The Company markets its products through social media and telemarketing. The Company seeks to expand its BioForce Eclipse nutritional powder for use into households throughout the United States. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, focuses to be the channels for the Companyâs Eclipse product lines. The Company private labels the powder through a manufacturer located in Virginia. The Company caters to the needs of customers with a focus on the elderly and athletes across numerous sports, ages, and economic backgrounds. The Company also focuses on offering its products for direct sales on its Website at www.bioforceeclipse.com. The Companyâs wholly owned subsidiary is Element Global, Inc.
BIOFORCE NANOSCIENCES HOLDINGS, INC. 
